HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MRX 408

a thrombus-specific ultrasound contrast agent; consists of phospholipid-coated microbubbles with a ligand capable of targeting the GPIIb/IIIa receptor

Also Known As:

MRX-408

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - MRX 408: 2

Experts

1.	Baker, M: 1 article (01/2000)
2.	Gabaeff, D: 1 article (01/2000)
3.	Hulett, R: 1 article (01/2000)
4.	Ihnat, D: 1 article (01/2000)
5.	Krupinski, E: 1 article (01/2000)
6.	McCreery, T: 1 article (01/2000)
7.	Metzger, P: 1 article (01/2000)
8.	Mills, J: 1 article (01/2000)
9.	Unger, E: 1 article (01/2000)

Related Diseases

1.

Thrombosis (Thrombus)

01/01/2000 - "After the use of MRX-408, there was improved visualization of thrombus within the grafts (P < 0.0001). "
01/01/2000 - "MRX-408 demonstrated better visualization of thrombus within AV fistulae. "
12/01/1998 - "Binding and lysing of blood clots using MRX-408."
01/01/2000 - "To evaluate the use of a new thrombus-specific ultrasound contrast agent, MRX-408, in the ultrasonic detection of thrombus in arteriovenous (AV) fistulae. "
12/01/1998 - "A thrombus-specific ultrasound contrast agent, MRX-408, has been developed recently. "

Related Drugs and Biologics

1.	Contrast Media